Cargando…

Reoperation after surgical treatment for benign prostatic hyperplasia: a systematic review

CONTEXT: Surgical treatment is important for male lower urinary tract symptom (LUTS) management, but there are few reviews of the risks of reoperation. OBJECTIVE: To systematically evaluate the current evidence regarding the reoperation rates of surgical treatment for LUTS in accordance with current...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Weixiang, Ding, Ting, Niu, Zhiping, Hao, Chunlin, Li, Chengbin, Xu, Zhicheng, Jing, Yuming, Qin, Weijun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10665564/ https://www.ncbi.nlm.nih.gov/pubmed/38027158 http://dx.doi.org/10.3389/fendo.2023.1287212

Ejemplares similares

The causal relationship between sarcopenic obesity factors and benign prostate hyperplasia
por: Rao, Xuezhi, et al.
Publicado: (2023)

Exposure to Di-2-ethylhexyl Phthalate and Benign Prostatic Hyperplasia, NHANES 2001-2008
por: Yang, Luchen, et al.
Publicado: (2022)

Upregulated Interleukin 21 Receptor Enhances Proliferation and Epithelial-Mesenchymal Transition Process in Benign Prostatic Hyperplasia
por: Xu, Deqiang, et al.
Publicado: (2019)

Impact of Diabetes Mellitus on Lower Urinary Tract Symptoms in Benign Prostatic Hyperplasia Patients: A Meta-Analysis
por: Xin, Caihong, et al.
Publicado: (2022)

Smoothened inhibition leads to decreased cell proliferation and suppressed tissue fibrosis in the development of benign prostatic hyperplasia
por: Liu, Jianmin, et al.
Publicado: (2021)

Exploring NCX4040, an Aspirin Derivative, as a Potential Treatment for Benign Prostatic Hyperplasia
por: Shahagadkar, Preksha Vaibhav, et al.
Publicado: (2021)

Benign Prostatic Hyperplasia
Publicado: (2015)

AB104. Hemiresection of the prostate in highly risk patients with benign prostate hyperplasia
por: Shang, Panfeng, et al.
Publicado: (2014)

Biexponential Apparent Diffusion Coefficients Values in the Prostate: Comparison among Normal Tissue, Prostate Cancer, Benign Prostatic Hyperplasia and Prostatitis
por: Liu, Xiaohang, et al.
Publicado: (2013)

Testosterone and benign prostatic hyperplasia
por: Jarvis, Thomas R, et al.
Publicado: (2015)

Current surgical procedures for benign prostatic hyperplasia and impression of new surgical modalities
por: Al Khayal, Abdullah M, et al.
Publicado: (2021)

Lasers are superfluous for the surgical management of benign prostatic hyperplasia in the developing world
por: Gupta, Narmada P., et al.
Publicado: (2009)

Economic Evaluation for Benign Prostatic Hyperplasia in Iran: Surgical Treatment or Dutasteride
por: Khedmati, Jamaleddin, et al.
Publicado: (2021)

Silodosin in the treatment of benign prostatic hyperplasia
por: Rossi, Maxime, et al.
Publicado: (2010)

Management of benign prostatic hyperplasia with silodosin
por: Yamanishi, Tomonori, et al.
Publicado: (2009)

Pathophysiology of clinical benign prostatic hyperplasia
por: Foo, Keong Tatt
Publicado: (2017)

Epidemiology of clinical benign prostatic hyperplasia
por: Lim, Kok Bin
Publicado: (2017)

Botulinum toxin and benign prostatic hyperplasia
por: Ng, Lay Guat
Publicado: (2018)

Solving the benign prostatic hyperplasia puzzle
por: Foo, Keong Tatt
Publicado: (2016)

Tissue microenvironment and benign prostatic hyperplasia
por: Wei, Xing, et al.
Publicado: (2019)

Laparoscopic simple prostatectomy with prostatic urethra preservation for benign prostatic hyperplasia
por: Xing, Nianzeng, et al.
Publicado: (2012)

The Impact of Benign Prostatic Hyperplasia Surgical Treatment with Turp Method on the Quality of Life
por: Milicevic, Snjezana
Publicado: (2011)

Prostatitis and benign prostatic hyperplasia: emerging infectious diseases?
por: Hennenfent, B
Publicado: (1997)

Zinc status in benign prostatic hyperplasia and prostate carcinoma
por: Wiwanitkit, Somsri, et al.
Publicado: (2012)

Surgical management of benign prostate hyperplasia in Nigeria: open prostatectomy versus transurethral resection of the prostate
por: Ofoha, Chimaobi Gideon, et al.
Publicado: (2021)

Serum omentin-1 level in patients with benign prostatic hyperplasia
por: He, Haiqing, et al.
Publicado: (2020)

Bipolar versus monopolar transurethral resection of the prostate for benign prostatic hyperplasia: safe in patients with high surgical risk
por: Yang, Er J., et al.
Publicado: (2016)

Linking Pre-Diabetes with Benign Prostate Hyperplasia. IGFBP-3: A Conductor of Benign Prostate Hyperplasia Development Orchestra?
por: Protopsaltis, Ioannis, et al.
Publicado: (2013)

Three-dimensional measurement and analysis of benign prostatic hyperplasia
por: Feng, Yankun, et al.
Publicado: (2021)

Genetically predicted alterations in thyroid function are associated with the risk of benign prostatic disease
por: Huang, Yan, et al.
Publicado: (2023)

Morphological Changes of Benign Prostatic Hyperplasia in Culture
por: McMahon, M. J., et al.
Publicado: (1973)

Benign Prostatic Hyperplasia: from Bench to Clinic
por: Yoo, Tag Keun, et al.
Publicado: (2012)

VASTI THERAPY IN THE MANAGEMENT OF BENIGN PROSTATE HYPERPLASIA
por: Gupta, Shivaji, et al.
Publicado: (1997)

Current Laser Treatments for Benign Prostatic Hyperplasia
por: Son, Hwancheol, et al.
Publicado: (2010)

Benign prostatic hyperplasia: An overview of existing treatment
por: Dhingra, Neelima, et al.
Publicado: (2011)

Therapeutic options in the treatment of benign prostatic hyperplasia
por: Sandhu, Jaspreet S
Publicado: (2009)

Unsolved Issues in Managing Benign Prostatic Hyperplasia
por: Oh, Seung-June
Publicado: (2013)

Recent advances in treatment for Benign Prostatic Hyperplasia
por: van Rij, Simon, et al.
Publicado: (2015)

Diagnosis and treatment of benign prostate hyperplasia in Asia
por: Foo, Keong Tatt
Publicado: (2015)

Chromosomal aberrations in benign prostatic hyperplasia patients
por: Altok, Muammer, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_j2ur5slsc647rr410jne57kpf2